IDEXX Laboratories, Inc. (IDXX)
639.79
-4.82
(-0.75%)
USD |
NASDAQ |
Feb 09, 16:00
639.00
-0.79
(-0.12%)
Pre-Market: 08:06
IDEXX Laboratories EPS Diluted (Quarterly) : 3.08 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Intuitive Surgical, Inc. | 2.205 |
| Boston Scientific Corp. | 0.4493 |
| Pfizer Inc. | -0.2898 |
| Revvity, Inc. | 0.8459 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 248.19M |
| Revenue (Quarterly) | 1.091B |
| Total Expenses (Quarterly) | 842.39M |
| Enterprise Value | 51.76B |
| Gross Profit Margin (Quarterly) | 60.35% |
| Profit Margin (Quarterly) | 22.76% |
| Earnings Yield | 2.04% |
| Operating Earnings Yield | 2.63% |